Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Allogene Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4284918A1 | Application | Knockdown oder knockout von einem oder mehreren von tap2, nlrc5, beta2m, trac, rfx5, rfxap und rfxank zur verringerung der t-zellerkennung allogener zellprodukte | C12N15/1138; C12N15/907; C12N2310/20; C12N2510/00; C12N2740/16043; C12N5/0636; C12N5/0638; C12N5/10; A61K2039/5156; A61K2039/5158; A61K35/17; A61K38/00; A61K39/001112; A61K48/005; A61P35/00; C07K14/705; C07K14/7051; C07K14/70535; C07K16/00; C07K16/18; C07K2317/622; C07K2319/03; C07K2319/30; C07K2319/33 | December 06, 2023 |
| EP4284937A1 | Application | Verfahren zur transduktion von immunzellen | C12N15/86; C12N2500/60; C12N2510/00; C12N2740/15041; C12N2740/16043; C12N5/0636; A61K2039/5156; A61K35/17; A61K39/0011; A61P35/00; C07K14/7051 | December 06, 2023 |
| AU2022292640A1 | Application | Selective targeting of host cd70+ alloreactive cells to prolong allogeneic car t cell persistence | A61K2039/5156; A61K2039/5158; A61K35/17; A61K39/0005; A61K39/001129; A61P35/00; C07K16/2875; C07K2317/31 | November 30, 2023 |
| US20230346934A1 | Application | Chimeric switch receptors for the conversion of immunesuppressive signals to costimulatory signals | A61P35/00; C07K14/70507; C07K14/7051; C07K14/70517; C07K14/70521; C07K14/71; C07K16/22; C07K16/2827; C07K2317/622; C07K2319/02; C07K2319/03; A61K39/4631; A61K2239/28; A61K2239/22; A61K39/4611; A61K2239/23; A61K2239/13; A61K39/4643; A61K2239/21 | November 02, 2023 |
| WO2023212675A1 | Application | Methods for donor cell analysis | C07K14/7051; C07K14/70539; G01N33/5094 | November 02, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer